A new report finds that Medicare Part D plans improperly authorized opioids meant to treat cancer pain to patients without cancer.March 3, 2023Check out STAT+Sponsored By Richard Hollawell STAT+ | Medicare Part D plans authorized opioid prescriptions for cancer pain — to people without cancer More than 800 Medicare beneficiaries received TIRF opioids for breakthrough cancer pain, even though they lacked a cancer diagnosis, an OIG report states. By Ed Silverman Report: Obesity could cost the world over $4 trillion a year by 2035 Over half the world's population will be either overweight or have obesity by 2035, according to the World Obesity Federation. By Julia Belluz Opinion: My son's time is running out due to a rare disease. The FDA needs to add more clinical trial flexibility The FDA's once-flexible Division of Rare Diseases and Medical Genetics is taking a more conservative approach to rare disease. By Judy Stecker More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments